ACT001, a metabolite of DMAMCL, binds to PAI-1, thereby inhibiting the PAI-1/PI3K/AKT pathway, which in turn suppresses glioma cell proliferation, invasion, and migration. The gene discussed is AKT1; the disease is central nervous system cancer.